English
Home > Products > Trimethyl borate

China Trimethyl borate Factory

Our company promises all users of the first-class products and the most satisfying post-sale service. We warmly welcome our regular and new customers to join us for Trimethyl borate,CAS NO 121-43-7,121-43-7, we could solve our customer problems asap and do the profit for our customer. For those who need excellent company and top quality , pls choose us , thanks !
Trimethyl borate, Our technical expertise, customer-friendly service, and specialized products and solutions make us/company name the first choice of customers and vendors. We have been looking for your inquiry. Let's set up the cooperation right now!

Related Products

Hot Products

  • Asciminib hydrochloride

    Asciminib hydrochloride

    Product Name:Asciminib hydrochloride
    Molecular Formula:C20H18ClF2N5O3. HCl
    Molecular Weight;486.3
    CAS Registry Number;2119669-71-3
  • Gabexate mesylate

    Gabexate mesylate

    Product Name:Gabexate mesylate
    Molecular Formula:C17H27N3O7S
    Molecular Weight;417.48
    CAS Registry Number;56974-61-9
  • 4-Amino-2-chloropyridine

    4-Amino-2-chloropyridine

    Product Name:4-Amino-2-chloropyridine
    Molecular Formula:C5H5ClN2
    Molecular Weight:128.56
    CAS Registry Number:14432-12-3
  • 1,5-Dichloropentane

    1,5-Dichloropentane

    Product Name:1,5-Dichloropentane
    Molecular Formula:C5H10Cl2
    Molecular Weight:141.04
    CAS Registry Number:628-76-2
  • L(+)-2-Aminobutyric acid

    L(+)-2-Aminobutyric acid

    Product Name:L(+)-2-Aminobutyric acid
    Molecular Formula:C4H9NO2
    Molecular Weight:103.12
    CAS Registry Number:1492-24-6
  • 4-Amino-2-(trifluoromethyl)benzonitrile

    4-Amino-2-(trifluoromethyl)benzonitrile

    Product Name:4-Amino-2-(trifluoromethyl)benzonitrile
    Molecular Formula:C8H5F3N2
    Molecular Weight:186.13
    CAS Registry Number:654-70-6
  • Related Blog
  • Reviews

  • CAS 148553-50-8 What is Pregabalin?

    Pregabalin is an anti-epileptic drug, also called an anticonvulsant. It works by slowing down impulses within the brain that cause seizures. Pregabalin also affects chemicals within the brain that send pain signals across the systema nervosum.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications.

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • What is Coenzyme Q10 CAS NO.303-98-0

    Coenzyme Q10 (CAS NO.303-98-0 ) is a fat-soluble antioxidant, which can activate the nutrition of human cells and cellular energy, and has the functions of improving human immunity, enhancing antioxidation, delaying ageing and enhancing human vitality.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept